logo

For the Inventor, By the Inventor

Ottawa, Canada

Robert G Korneluk

This inventor holds 30 USPTO granted patents and 4 published patent applications, primarily in Cancer Therapy. Top assignees: University of Ottawa, Aegera Therapeutics, Inc., Apoptogen, Inc.. Active years: 1999-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert G Korneluk. Retrieved from https://idiyas.com/inventor/robert-g-korneluk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 194(Granted Patents)


Location History:

  • Ontario, CA (2000 - 2006)
  • Ottawa, CA (1999 - 2019)

Company Filing History:

goldMedal11 out of 166 
 
University of Ottawa
 patents
silverMedal10 out of 24 
 
Aegera Therapeutics, Inc.
 patents
bronzeMedal5 out of 5 
 
Apoptogen, Inc.
 patents
4. 2 out of 2 
 
Dianovix, Inc.
 patents
5. 1 out of 5 
 
Children's Hospital of Eastern Ontario Research Institute Inc.
 patents
6. 1 out of 256 
 
Research Development Corporation of Japan
 patents
7. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...
Areas of Expertise:
Cancer Therapy
Apoptosis Modulation
Multiple Sclerosis
IAP Gene Family
Neuronal Apoptosis
Diagnostic Markers
Therapeutic Methods
Male Fertility
Antisense Oligonucleotides
Drug Screening
Proliferative Diseases
XAF Genes
30 patents (USPTO):Explore Patents
1. 10441654 - SMC combination therapy for the treatment of cancer (2019-10-15),
2. 8021840 - Diagnostic marker for interferon responsiveness in multiple sclerosis (2011-09-20),
3. 7858309 - Method for differentiating between multiple sclerosis subtypes (2010-12-28),
4. 7776552 - Mammalian IAP gene family, primers, probes and detection methods (2010-08-17),
5. 7294713 - Antisense IAP oligonucleotides and uses thereof (2007-11-13),
6. 7235372 - Use of neuronal apoptosis inhibitor protein (NAIP) (2007-06-26),
7. 7087584 - Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease (2006-08-08),
8. 7067281 - Mammalian IAP gene family, primers, probes and detection methods (2006-06-27),
9. 6994957 - Use of neuronal apoptosis inhibitor protein (NAIP) (2006-02-07),
10. 6977158 - Mammalian IAP gene family, primers, probes, and detection methods (2005-12-20),
11. 6946544 - XAF genes and polypeptides: methods and reagents for modulating apoptosis (2005-09-20),
12. 6797473 - Methods and compounds for modulating male fertility (2004-09-28),
13. 6709866 - Methods for enhancing survival of a neuron (2004-03-23),
14. 6689562 - Mammalian IAP gene family, primers, probes and detection methods (2004-02-10),
15. 6673917 - Antisense IAP nucleic acids and uses thereof (2004-01-06),

Title: The Innovative Journey of Robert G Korneluk

Introduction:

Robert G Korneluk is a distinguished inventor based in Ottawa, Canada, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Robert G Korneluk holds several patents in various technological domains, showcasing his continuous commitment to pushing the boundaries of innovation.

Career Highlights:

With a career spanning over two decades, Robert G Korneluk has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them. His innovative approach has led to the creation of several cutting-edge technologies that have revolutionized the industry.

Collaborations:

Throughout his career, Robert G Korneluk has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Robert G Korneluk's passion for innovation, coupled with his technical expertise, has cemented his reputation as a trailblazing inventor in the technology sector. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…